Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2
{{output}}
Background and purpose: Complement factor C2 is a potential therapeutic target in immune-mediated neuropathies. However, literature suggests that classical complement pathway activation may proceed to C3 in the absence of C2, a s... ...
